|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Sarepta Therapeutics (NASDAQ: SRPT) through any online brokerage.
The latest price target for Sarepta Therapeutics (NASDAQ: SRPT) was reported by Credit Suisse on October 15, 2021. The analyst firm set a price target for 95.00 expecting SRPT to rise to within 12 months (a possible 18.39% upside). 24 analyst firms have reported ratings in the last year.
The stock price for Sarepta Therapeutics (NASDAQ: SRPT) is $80.24 last updated Fri Oct 22 2021 20:00:03 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Sarepta Therapeutics.
Sarepta Therapeutics’s $Q3 earnings are confirmed for after-market on $November 4, 2021.
There is no upcoming split for Sarepta Therapeutics.
Sarepta Therapeutics is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.